Zelan Berhad (KLSE:ZELAN)

Singular Genomics Systems Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	46	68	59	68	97
Market Cap Growth	-23.08%	-31.25%	14.29%	-12.50%	-30.44%	35.29%
Enterprise Value	382	423	537	552	571	624
Last Close Price	0.03	0.06	0.08	0.07	0.08	0.12
PE Ratio	-	-	1.03	43.39	21.51	2.68
PS Ratio	0.53	1.16	2.23	1.17	1.47	1.87
PB Ratio	-0.23	-0.50	0.43	0.61	0.81	1.11
P/TBV Ratio	-	-	0.43	0.61	0.80	1.10
P/FCF Ratio	0.35	0.90	1.15	1.46	1.07	1.34
P/OCF Ratio	0.35	0.89	1.15	1.46	1.07	1.34
EV/Sales Ratio	9.61	10.54	17.71	10.94	12.44	12.02
EV/EBITDA Ratio	-	-	50.43	34.26	92.79	11.51
EV/EBIT Ratio	-	-	50.80	34.64	96.34	11.55
EV/FCF Ratio	6.42	8.15	9.12	13.62	9.04	8.58
Debt / Equity Ratio	-4.05	-4.01	2.64	5.02	6.00	6.13
Debt / EBITDA Ratio	-	-	37.93	30.04	81.78	9.91
Debt / FCF Ratio	6.13	7.20	6.96	11.94	7.97	7.39
Asset Turnover	0.07	0.07	0.04	0.06	0.05	0.06
Quick Ratio	0.27	0.30	1.63	0.27	0.30	0.31
Current Ratio	0.27	0.33	1.64	0.28	0.32	0.34
Return on Equity (ROE)	-743.19%	-807.30%	51.92%	1.51%	3.67%	50.97%
Return on Assets (ROA)	-25.16%	-24.92%	0.85%	1.21%	0.43%	4.08%
Return on Capital (ROIC)	-36.35%	-35.96%	1.15%	1.70%	0.61%	5.50%
Return on Capital Employed (ROCE)	-	-	1.90%	2.90%	1.10%	9.30%
Earnings Yield	-1203.11%	-542.78%	96.73%	2.31%	4.65%	37.27%
FCF Yield	281.75%	111.71%	87.15%	68.49%	93.49%	74.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.